Anti-psychotic drugs act synergistically in combination with antifungal drugs to inhibit drug-resistant Cryptococcus neoformans and Candida albicans
Magali Ayala, Alifia Jakamartana, Rodrigo Mamede Dos Santos Costa, Eric Cheuk-Kiu Cheung, Joseph M. Bednarek, Christian T. Moreau, Jessica C. S. Brown · 2026
Read Anti-psychotic drugs act synergistically in combination with antifungal drugs to inhibit drug-resistant Cryptococcus neoformans and Candida albicans by Magali Ayala, Alifia Jakamartana, Rodrigo Mamede Dos Santos Costa, Eric Cheuk-Kiu Cheung, Joseph M. Bednarek, Christian T. Moreau, Jessica C. S. Brown (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13621842.txt.
Description
Magali Ayala and co-authors pair an antipsychotic drug with antifungals against resistant fungi in this 2026 study. Systemic fungal infections kill an estimated 3.8 million people a year, and only five drug classes exist. Drug-resistant strains of two major fungi make new options urgent.
The team found that chlorpromazine, a psychiatric drug, acts in synergy with two standard antifungals, beating even resistant strains of both fungi. A genome-wide screen in mutant fungi pointed to membrane and fat pathways. Treated cells showed swollen lipid droplets and fewer of them, which may trap fats the cell needs. The authors suggest the drug and its relatives could be repurposed for hard fungal infections.
Catalog record
| CREATOR | Magali Ayala, Alifia Jakamartana, Rodrigo Mamede Dos Santos Costa, Eric Cheuk-Kiu Cheung, Joseph M. Bednarek, Christian T. Moreau, Jessica C. S. Brown |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |